title: Effects of Montelukast on free radical production in whole blood and isolated human polymorphonuclear neutrophils (PMNs) in asthmatic children.
abstract: Montelukast is a highly selective leukotriene-receptor antagonist (LTRA). It is widely used in the treatment of bronchial asthma, primarily as an adjunct to corticosteroids. Reactive oxygen species (ROSs) play an important role in the pathogenesis of asthma and oxidative stress contributing to the initiation and worsening of inflammatory respiratory disorders, such as asthma. Antioxidant drugs may have a role in minimizing or preventing damage in asthmatic children. The aim of this study was to assess the antioxidant effect of montelukast on the production of free radicals in the whole blood and polymorphonuclear neutrophils (PMNs) in asthmatic children. A group of 48 (38 males and 10 females), apparently healthy asthmatic children were recruited with ages ranging between 6 and 14 years. In asthmatic children, base line (premedication) and post medication free radicals activity in the whole blood and polymorphonuclear neutrophils (PMNs) was determined by measuring chemiluminescence (CL) response through chemiluminescence luminometer. Free radical productions were significantly decreased in the whole blood, when stimulated with Phorbol Myristate Acetate (p < 0.04) and Opsonised Zymosan (p < 0.05). The free radicals were also significantly decreased in isolated polymorphonuclear neutrophils (PMNs) when stimulated with Opsonised Zymosan (p < 0.05) after the post medication treatment of montelukast in asthmatic children. Montelukast decreased the reactive oxygen species production, both in the whole blood as well as isolated PMNs in asthmatic children.
authors: Department of Paediatrics, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
authors: Muslim M
authors: MM
authors: Al Saadi
authors: Sultan Ayoub
authors: SA
authors: Meo
authors: Ali
authors: A
authors: Mustafa
authors: Ahmed
authors: A
authors: Shafi
authors: Ali S Al
authors: AS
authors: Tuwajri
keywords: Antioxidant; Bronchial asthma; Free radicals production; Montelukast
references: QJM. 2005 Mar;98(3):171-82
references: 15728398
references: Respir Med. 2005 Jun;99(6):655-62
references: 15878481
references: Blood. 2000 Feb 1;95(3):1069-77
references: 10648424
references: Immunology. 1988 May;64(1):51-9
references: 2838420
references: Curr Med Chem. 2007;14(18):1966-77
references: 17691939
references: Am J Respir Crit Care Med. 2005 Feb 15;171(4):315-22
references: 15542792
references: Pharmacol Res. 2006 Jul;54(1):65-71
references: 16584888
references: Am J Respir Crit Care Med. 2006 Apr 1;173(7):718-28
references: 16387808
references: Exp Mol Med. 2006 Apr 30;38(2):109-18
references: 16672764
references: Adv Ther. 2009 Jun;26(6):575-87
references: 19562275
references: Biochem Biophys Res Commun. 1986 Mar 13;135(2):556-65
references: 3008726
references: Ther Clin Risk Manag. 2007 Oct;3(5):885-92
references: 18473012
references: Eur J Pharmacol. 2007 Feb 14;557(1):69-75
references: 17173892
references: Curr Ther Res Clin Exp. 2005 Jul;66(4):279-93
references: 24672130
references: Paediatr Child Health. 2007 Apr;12(4):309-10
references: 19030376
references: N Engl J Med. 2007 Nov 1;357(18):1841-54
references: 17978293
references: Am J Respir Crit Care Med. 2003 Feb 1;167(3):379-83
references: 12406832
references: Br J Pharmacol. 2009 Jan;156(1):105-15
references: 19068077
references: Brain Inj. 2009 Jun;23(6):577-84
references: 19484631
references: Allergy. 2003 Dec;58(12):1268-76
references: 14616102
references: J Toxicol Clin Toxicol. 2004;42(3):333-4
references: 15362605
references: Proc Natl Acad Sci U S A. 2000 Jan 18;97(2):823-8
references: 10639164